rs1053004
|
|
Mean Corpuscular Volume (result)
|
A |
0.700 |
GeneticVariation
|
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
rs1053004
|
|
Liver carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
<b>Conclusions:</b> The meta-analysis showed that <i>STAT3</i> rs1053004 polymorphism may be the risk for developing chronic HBV infection but not associated with HCC.
|
31160486 |
2019 |
rs1053004
|
|
Liver carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
In multivariate regression analyses, multiplicative interaction of rs1053004 with T1674C/G significantly increased HCC risk, whereas rs2293152 and A1726C interaction reduced it, adjusting for covariates including HBV mutations in the enhancer II/basal core promoter/precore region; the interaction of rs4796793 with preS2 start codon mutation significantly increased HCC risk, adjusting for covariates including HBV mutations in the preS region.
|
23386590 |
2013 |
rs1053004
|
|
Liver carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
These findings suggest that the SNP rs1053004 in STAT3 might contribute to HCC susceptibility and could be used as a genetic marker for HCC in the Thai population.
|
26163643 |
2015 |
rs1053004
|
|
Liver carcinoma
|
|
0.040 |
GeneticVariation
|
BEFREE |
These results illustrate that perhaps rs1053004 polymorphisms in the STAT3 gene participated in the progression of hepatitis B to HCC in Iranian people.
|
29307341 |
2017 |
rs1053004
|
|
Hepatitis B
|
|
0.030 |
GeneticVariation
|
BEFREE |
These results illustrate that perhaps rs1053004 polymorphisms in the STAT3 gene participated in the progression of hepatitis B to HCC in Iranian people.
|
29307341 |
2017 |
rs1053004
|
|
Hepatitis B
|
|
0.030 |
GeneticVariation
|
BEFREE |
<b>Conclusions:</b> The meta-analysis showed that <i>STAT3</i> rs1053004 polymorphism may be the risk for developing chronic HBV infection but not associated with HCC.
|
31160486 |
2019 |
rs1053004
|
|
Hepatitis B
|
|
0.030 |
GeneticVariation
|
BEFREE |
STAT3 rs1053004 and rs1053005 polymorphisms and haplotypes formed by rs1053004 and rs1053005 are associated with chronic HBV infection and the haplotypes appear to be also associated with the development of liver disease.
|
29609539 |
2018 |
rs1053004
|
|
Hepatitis B, Chronic
|
|
0.020 |
GeneticVariation
|
BEFREE |
Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma.
|
29307341 |
2017 |
rs1053004
|
|
Complete atrioventricular block
|
|
0.020 |
GeneticVariation
|
BEFREE |
The genotype of SNP rs1053004 (CC versus TT+TC) was significantly associated with an increased risk when compared with CHB patients (OR=1.83, 95% CI=1.13-2.99, P=0.015).
|
26163643 |
2015 |
rs1053004
|
|
Complete atrioventricular block
|
|
0.020 |
GeneticVariation
|
BEFREE |
The purpose of this research is to evaluate the single nucleotide polymorphism (SNP) rs1053004 in the STAT3 gene in CHB patients and individuals who suffer from HCC.
|
29307341 |
2017 |
rs1053004
|
|
Hepatitis B, Chronic
|
|
0.020 |
GeneticVariation
|
BEFREE |
Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
|
26163643 |
2015 |
rs1053004
|
|
Secondary malignant neoplasm of colon and/or rectum
|
|
0.010 |
GeneticVariation
|
BEFREE |
Association of <i>STAT</i>-3 rs1053004 and <i>VDR</i> rs11574077 With FOLFIRI-Related Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients.
|
29706892 |
2018 |
rs1053004
|
|
Malignant neoplasm of pancreas
|
|
0.010 |
GeneticVariation
|
BEFREE |
In conclusion, the current study provided evidence that rs1053004 T > C in 3'UTR of STAT3 may decrease the risk of PC through up-regulating the gene expression.
|
27577070 |
2016 |
rs1053004
|
|
Liver diseases
|
|
0.010 |
GeneticVariation
|
BEFREE |
STAT3 rs1053004 and rs1053005 polymorphisms and haplotypes formed by rs1053004 and rs1053005 are associated with chronic HBV infection and the haplotypes appear to be also associated with the development of liver disease.
|
29609539 |
2018 |
rs1053004
|
|
Squamous cell carcinoma of tongue
|
|
0.010 |
GeneticVariation
|
BEFREE |
The expression level of STAT3 protein in tumor tissues of patients with <i>STAT3</i> rs1053004 locus GG genotype was significantly higher than in patients with type GA, and it was the lowest in patients with type AA.<b>Conclusion:</b> Polymorphisms in the <i>SP1</i> rs1353058818 and <i>STAT3</i> rs1053004 loci are associated with the risk of human TSCC.
|
31270251 |
2019 |
rs1053004
|
|
Neoplasms
|
|
0.010 |
GeneticVariation
|
BEFREE |
The expression level of STAT3 protein in tumor tissues of patients with <i>STAT3</i> rs1053004 locus GG genotype was significantly higher than in patients with type GA, and it was the lowest in patients with type AA.<b>Conclusion:</b> Polymorphisms in the <i>SP1</i> rs1353058818 and <i>STAT3</i> rs1053004 loci are associated with the risk of human TSCC.
|
31270251 |
2019 |
rs1053004
|
|
Pancreatic carcinoma
|
|
0.010 |
GeneticVariation
|
BEFREE |
In conclusion, the current study provided evidence that rs1053004 T > C in 3'UTR of STAT3 may decrease the risk of PC through up-regulating the gene expression.
|
27577070 |
2016 |
rs1053005
|
|
Liver diseases
|
|
0.010 |
GeneticVariation
|
BEFREE |
STAT3 rs1053004 and rs1053005 polymorphisms and haplotypes formed by rs1053004 and rs1053005 are associated with chronic HBV infection and the haplotypes appear to be also associated with the development of liver disease.
|
29609539 |
2018 |
rs1053005
|
|
Hepatitis B
|
|
0.010 |
GeneticVariation
|
BEFREE |
STAT3 rs1053004 and rs1053005 polymorphisms and haplotypes formed by rs1053004 and rs1053005 are associated with chronic HBV infection and the haplotypes appear to be also associated with the development of liver disease.
|
29609539 |
2018 |
rs1053005
|
|
Malignant neoplasm of pancreas
|
|
0.010 |
GeneticVariation
|
BEFREE |
We first explored the associations between two common variants (rs1053004 and rs1053005) and PC risk in 774 PC cases and 777 controls.
|
27577070 |
2016 |
rs1053005
|
|
Obesity
|
|
0.010 |
GeneticVariation
|
BEFREE |
GG genotype at rs1053005 had lower risks of both general obesity and central obesity (OR=0.40, p=0.034; OR=0.42, p=0.007, respectively) compared with AA genotype.
|
25014397 |
2014 |
rs1053005
|
|
Hepatitis B, Chronic
|
|
0.010 |
GeneticVariation
|
BEFREE |
Association of polymorphism rs1053005 in STAT3 with chronic hepatitis B virus infection in Han Chinese population.
|
29609539 |
2018 |
rs1053005
|
|
Hashimoto Disease
|
|
0.010 |
GeneticVariation
|
BEFREE |
The allele A from rs1053005 was significantly less frequent in both GD and HT patients (P = 0.0024, OR = 0.6958, 95%CI = 0.5508-0.8788; P = 0.0091, OR = 0.7013, 95%CI = 0.5397-0.9112, respectively).
|
24081513 |
2013 |
rs1053005
|
|
Autoimmune thyroid disease (AITD)
|
|
0.010 |
GeneticVariation
|
BEFREE |
The allele A and AA genotype of SNP rs1053005 may protect individuals from the susceptibility to AITD and their frequency decreased in AITD patients.
|
24081513 |
2013 |